However, high IGF2BP2 mRNA upregulation rate with a relative low genomic copy number gain rate suggested that other regulation mechanisms might play important roles in IGF2BP2 overexpression in pancreatic cancer. The gene discussed is IGF2BP2; the disease is familial pancreatic carcinoma.